Lloret-Madrid P, Boluda B, Martinez-Lopez J, Bergua J, Rodriguez Arboli E, Labrador J, Sossa C, Gil C, Algarra L, Lavilla-Rubira E, Serrano J, de Rueda B, Ibanez F, Gonzalez Gonzalez BJ, Amigo ML, Garcia Belmonte D, Rodriguez-Medina C, Gomez-Roncero MI, Colorado M, Lopez Lorenzo JL, Tormo M, Arce Fernandez O, Cano-Ferri I, Solana-Altabella A, Foncillas MA, Alfonso Pierola A, Vives S, Nunez MV, Lopez-Vidal H, Perez-Santaolalla E, Hermosin Ramos L, Garcia Boyero R, Llorente Gonzalez L, Roldan A, Calderon SC, Infante JB, Olave T, Garcia-Suarez J, de Laiglesia A, Rodriguez-Veiga R, Trigo F, Martinez-Cuadron D, Montesinos P. Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study. Cancer. 2025 Jan 1;131(1):e35696. doi: 10.1002/cncr.35696. PubMed PMID: 39748608.
AÑO: 2025; IF: 5.1